Catherine T. Doherty

Executive Vice President · Quest Diagnostics

Diagnostic Laboratory Services

Catherine T. Doherty is executive vice president of Quest Diagnostics, with responsibility for health systems, the Corewell Health joint venture and Project Nova. Her career at Quest has encompassed accounting, hospital and physician services, clinical franchises and regional operations.

Last reviewed: Nov 2, 2026

Catherine T. Doherty

Executive Vice President
Quest Diagnostics

Last Reviewed: November 2, 2026

Executive Summary

Catherine T. Doherty is executive vice president of Quest Diagnostics, with responsibility for health systems, the Corewell Health joint venture and Project Nova. Her career at Quest has encompassed accounting, hospital and physician services, clinical franchises and regional operations.

Career Highlights

  • Joined Quest in 1990 and progressed through accounting, hospital services and clinical-franchise leadership.
  • Oversaw the launch of Quest’s consumer-initiated testing business.
  • Moved to health-system, joint-venture and modernization responsibilities in November 2026.

Professional Journey

Doherty began her career at KPMG after studying business and accounting at Montclair State. She subsequently became assistant controller at adidas. When that department relocated to South Carolina, she chose to pursue opportunities nearer her New Jersey home. She joined Quest predecessor Metpath, then a Corning subsidiary, in 1990 and went on to hold positions including chief accounting officer, vice president of communications and investor relations, and vice president of finance and administration for the hospital business.

Her later assignments included vice president of the Office of the Chairman, vice president of hospital services and senior vice president of physician services. From January 2013 to March 2022, she was senior vice president and group executive for clinical franchise solutions and marketing. The portfolio encompassed general health and wellness, cardiovascular and metabolic testing, infectious disease and immunology, and drug monitoring. She also oversaw the launch of consumer-initiated testing and retained responsibility for it from January 2020 through January 2023.

In March 2022, Doherty took charge of regional diagnostic information services, the commercial organization and marketing. AmeriPath’s anatomic pathology business joined her remit in 2024, when marketing moved out of her portfolio. Her work also included the company’s operational quality and efficiency programs.

Effective November 1, 2026, she moved to an executive vice president assignment covering health systems, the Corewell Health joint venture and Project Nova, the modernization of Quest’s order-to-cash processes and supporting technology. Quest has announced her retirement for July 2027. Doherty also sponsors Quest’s Women in Leadership employee network and serves on the Feliciano School of Business advisory board.

Education

Doherty earned a degree in business administration, with an accounting concentration, from Montclair State University. She is a certified public accountant.